Bunge (BG) analyst forecast and price target
Analyst forecast
Consensus of 11 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $150.00 from $145.00 | Apr 30, 2026 |
| Barclays | Maintained | Overweight | $145.00 from $135.00 | Apr 1, 2026 |
| JP Morgan | Maintained | Overweight | $134.00 from $130.00 | Mar 24, 2026 |
| BMO Capital | Maintained | Outperform | $135.00 from $130.00 | Mar 11, 2026 |
| Morgan Stanley | Maintained | Overweight | $140.00 from $130.00 | Mar 11, 2026 |
| Morgan Stanley | Maintained | Overweight | $130.00 from $120.00 | Feb 5, 2026 |
| UBS | Maintained | Buy | $145.00 from $108.00 | Feb 5, 2026 |
| Barclays | Maintained | Overweight | $135.00 from $120.00 | Feb 5, 2026 |
| JP Morgan | Maintained | Overweight | $130.00 from $117.00 | Feb 5, 2026 |
| JP Morgan | Maintained | Overweight | $117.00 from $109.00 | Jan 21, 2026 |
| Morgan Stanley | Upgraded | Equal-Weight → Overweight | $120.00 from $95.00 | Dec 16, 2025 |
| B of A Securities | Maintained | Buy | $112.00 from $95.00 | Dec 2, 2025 |
| Barclays | Upgraded | Equal-Weight → Overweight | $120.00 from $105.00 | Nov 6, 2025 |
| Barclays | Maintained | Equal-Weight | $105.00 from $85.00 | Oct 21, 2025 |
| Stephens & Co. | Maintained | Overweight | $115.00 from $85.00 | Oct 17, 2025 |
| JP Morgan | Maintained | Overweight | $107.00 from $95.00 | Oct 16, 2025 |
| BMO Capital | Maintained | Outperform | $110.00 from $95.00 | Oct 16, 2025 |
| JP Morgan | Initiated Coverage | Overweight | $95.00 | Aug 20, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $83.00 from $74.00 | Aug 12, 2025 |
| Stephens & Co. | Maintained | Overweight | $85.00 from $90.00 | May 8, 2025 |
Frequently asked questions
Is BG a buy, sell, or hold?
Analysts covering Bunge currently average a Buy rating: 11 buy, 0 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on BG?
On Apr 30, 2026, Barclays maintained Bunge at Overweight with a price target of $150.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.